-
IPO Outlook: Inotek's Vision For The Future
Wednesday, February 4, 2015 - 3:28pm | 1080Inotek Pharmaceuticals Corp (NASDAQ: ITEK), founded in 1999, is a clinical-stage biopharmaceutical company centered on the discovery, development and commercialization of therapies to treat glaucoma. Glaucoma is condition where the eye is unable to properly drain fluid, which leads to a buildup...